Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

221 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Radiation oncology in the new virtual and digital era.
Aznar MC, Bacchus C, Coppes RP, Deutsch E, Georg D, Haustermans K, Hoskin P, Krause M, Lartigau EF, Löck S, Offersen B, Overgaard J, Thwaites DI, van der Kogel AJ, van der Heide UA, Valentini V, Baumann M. Aznar MC, et al. Among authors: van der heide ua, van der kogel aj. Radiother Oncol. 2021 Jan;154:A1-A4. doi: 10.1016/j.radonc.2020.12.031. Epub 2020 Dec 30. Radiother Oncol. 2021. PMID: 33387585 Free PMC article. No abstract available.
Comparison of biologically equivalent dose-volume parameters for the treatment of prostate cancer with concomitant boost IMRT versus IMRT combined with brachytherapy.
Pieters BR, van de Kamer JB, van Herten YR, van Wieringen N, D'Olieslager GM, van der Heide UA, Koning CC. Pieters BR, et al. Among authors: van herten yr, van der heide ua, van wieringen n, van de kamer jb. Radiother Oncol. 2008 Jul;88(1):46-52. doi: 10.1016/j.radonc.2008.02.023. Epub 2008 Apr 2. Radiother Oncol. 2008. PMID: 18378028
Prostate tumor delineation using multiparametric magnetic resonance imaging: Inter-observer variability and pathology validation.
Steenbergen P, Haustermans K, Lerut E, Oyen R, De Wever L, Van den Bergh L, Kerkmeijer LG, Pameijer FA, Veldhuis WB, van der Voort van Zyp JR, Pos FJ, Heijmink SW, Kalisvaart R, Teertstra HJ, Dinh CV, Ghobadi G, van der Heide UA. Steenbergen P, et al. Among authors: van den bergh l, van der heide ua, van der voort van zyp jr. Radiother Oncol. 2015 May;115(2):186-90. doi: 10.1016/j.radonc.2015.04.012. Epub 2015 Apr 29. Radiother Oncol. 2015. PMID: 25935742 Free article.
Magnetic resonance imaging for prostate cancer radiotherapy.
Dinh CV, Steenbergen P, Ghobadi G, Heijmink SW, Pos FJ, Haustermans K, van der Heide UA. Dinh CV, et al. Among authors: van der heide ua. Phys Med. 2016 Mar;32(3):446-51. doi: 10.1016/j.ejmp.2016.01.484. Epub 2016 Feb 5. Phys Med. 2016. PMID: 26858164 Free article. Review.
Standard whole prostate gland radiotherapy with and without lesion boost in prostate cancer: Toxicity in the FLAME randomized controlled trial.
Monninkhof EM, van Loon JWL, van Vulpen M, Kerkmeijer LGW, Pos FJ, Haustermans K, van den Bergh L, Isebaert S, McColl GM, Smeenk RJ, Noteboom J, Walraven I, Peeters PHM, van der Heide UA. Monninkhof EM, et al. Among authors: van den bergh l, van der heide ua, van vulpen m, van loon jwl. Radiother Oncol. 2018 Apr;127(1):74-80. doi: 10.1016/j.radonc.2017.12.022. Epub 2018 Jan 11. Radiother Oncol. 2018. PMID: 29336835 Free article. Clinical Trial.
221 results